首页> 外国专利> METHOD FOR DETERMINING THE DURATION OF CHEMOTHERAPY OF RESPIRATORY TUBERCULOSIS IN CHILDREN AND ADOLESCENTS WITH THE FIRST DETERMINED FROM THE SURGICAL MATERIAL MULTIPLE AND EXTENDED DRUG-RESISTANT TUBERCULOSIS MYCOBACTERIA

METHOD FOR DETERMINING THE DURATION OF CHEMOTHERAPY OF RESPIRATORY TUBERCULOSIS IN CHILDREN AND ADOLESCENTS WITH THE FIRST DETERMINED FROM THE SURGICAL MATERIAL MULTIPLE AND EXTENDED DRUG-RESISTANT TUBERCULOSIS MYCOBACTERIA

机译:首次从外科手术材料和扩展耐药性结核菌中确定的儿童和青少年呼吸道结核的化学治疗持续时间的测定方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medical industry, namely to a method for determining duration of chemotherapy for respiratory tuberculosis in children and adolescents. Method for determining the duration of chemotherapy of respiratory tuberculosis in children and adolescents with the first and determined from the surgical material multiple and broad drug-resistant tuberculosis mycobacteria, where after surgical treatment of respiratory tuberculosis in children and adolescents, microbiological examination of surgical material is performed and a group of patients with a newly determined multiple and broad drug-resistant tuberculosis mycobacteria are isolated, where the length of the chemotherapy is prescribed for the patients of this group for 3 months, if the length of the chemotherapy before the operation is at least 6 months, taking into account the drug sensitivity at the source of the infection, the surgical material shows the tuberculosis mycobacterium DNA, DST are performed, and growth of MBTC from the surgical material by the sowing method is not detected, and in the computed tomography of chest organs 2 months after the operation, the signs of the progression of the tuberculosis process are not detected, the length of the chemotherapy is prescribed for the patients of this group for 6 months, if preoperative chemotherapy was performed without taking into account the risk of MDR tuberculosis mycobacterium, the surgical material shows tuberculosis mycobacterium DNA, DST are performed, and MBTC growth from the surgical material by the sowing method is not detected, and in the computed tomography of chest organs 2 months after the operation, the signs of progression of the tuberculosis process are not detected, and setting for the patients of this group the duration of chemotherapy for 9 months if the length of the chemotherapy before the operation is at least 6 months taking into account drug sensitivity at the source of infection, during microbiological examination of the operative material by PCR method, DNA of mycobacteria tuberculosis is detected by sowing, growth of MBTC is detected and DST are performed, and in computed tomography of chest organs 2 months after the operation, signs of progression of the tuberculosis process are not detected.;EFFECT: proposed method is effective in determining duration of chemotherapy for respiratory tuberculosis.;1 cl, 1 tbl
机译:发明领域本发明涉及医学工业,即一种确定儿童和青少年呼吸道结核的化学疗法的持续时间的方法。首先确定并从手术材料中确定多重耐药结核分枝杆菌的方法确定儿童和青少年呼吸道结核化疗的持续时间的方法。如果手术前的化疗时间为,则对一组新近确定的多发性和广泛耐药结核分枝杆菌的患者进行隔离,其中该组患者的化疗时间为3个月至少6个月,考虑到感染源的药物敏感性,手术材料显示已进行结核分枝杆菌DNA,DST的操作,并且未检测到播种方法从手术材料中产生的MBTC增长,并且在计算结果中术后2个月胸部器官的断层扫描,由于未检测到结核病进程的进展,因此该组患者的化疗时间为6个月,如果在不考虑MDR结核分枝杆菌风险的情况下进行术前化疗,则手术材料显示结核分枝杆菌DNA进行DST操作,并且未检测到播种方法从手术材料中产生的MBTC增长,并且在术后2个月的胸部器官计算机X线断层扫描中,未检测到结核病进展的迹象,并且未设置如果考虑到感染源的药物敏感性,在通过PCR方法对手术材料进行微生物学检查,分枝杆菌DNA的过程中,该组患者的化疗持续时间为9个月(如果手术前的化疗时间至少为6个月)通过播种检测结核病,检测MBTC的生长并进行DST,然后计算术后2个月对胸部器官进行X线断层扫描,未发现结核病进展的迹象。效果:建议的方法可有效确定呼吸道结核的化疗时间; 1 cl,1 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号